Revolutions Medical CORP: 10-Q filed 2014-11-14
What Revolutions Medical CORP reported in its quarterly report filed 2014-11-14 (fiscal Q3 2014): 32 published measures, 87 facts as tagged in accession 0001437749-14-020882.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-11-14
- Fiscal period
- fiscal Q3 2014
- Accession
- 0001437749-14-020882 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Revolutions Medical CORP filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 595,544 | USD | |
| At 2013-12-31 | 686,134 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 9,657,593 | USD | |
| At 2013-12-31 | 7,924,434 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 16,610 | USD | |
| At 2013-12-31 | 932 | USD | |
| At 2013-09-30 | 3,372 | USD | |
| At 2012-12-31 | 54 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | -2,798,483 | USD | 273 |
| 1996-08-16 to 2014-09-30 | -47,161,743 | USD | 6620 |
| 2013-01-01 to 2013-09-30 | -4,048,052 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | -244,085 | USD | 273 |
| 2013-01-01 to 2013-09-30 | -495,842 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 53,799 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 58,847 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 2,363 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 5,454 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 267,400 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 520,970 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | -7,637 | USD | 273 |
| 2013-01-01 to 2013-09-30 | -21,810 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 193,524 | USD | |
| At 2013-12-31 | 270,189 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 117,478 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 625,633 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -784,908 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -2,507,696 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -997,552 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -3,683,340 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 268,218 | USD | |
| At 2013-12-31 | 282,428 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 156,565 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 676,537 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 207,414 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 474,098 | USD | 273 |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 133,802 | USD | |
| At 2013-12-31 | 133,517 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 322,198 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 1,109,140 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 505,249 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 2,216,797 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 245,289 | USD | |
| At 2013-12-31 | 278,564 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -462,710 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -1,398,556 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -492,303 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -1,466,543 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 35,208 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 35,208 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 1,338 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 2,640 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 168,716,800 | shares | |
| At 2013-12-31 | 107,039,034 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 38,000,978 | USD | |
| At 2013-12-31 | 37,087,921 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | -9,062,049 | USD | |
| At 2013-12-31 | -7,238,300 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 402,906 | USD | |
| At 2013-12-31 | 446,382 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 209,382 | USD | |
| At 2013-12-31 | 176,193 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 133,802 | USD | |
| At 2013-12-31 | 133,517 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -895,028 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -2,798,483 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -925,666 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -4,048,052 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 281,710 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 1,024,600 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 480,460 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 2,144,070 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 59,588 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 64,851 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 22,888 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 66,940 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 24,789 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 72,727 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 7,352 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 7,876 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 122,700 | USD | 273 |
| 2013-01-01 to 2013-09-30 | -753 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -110,120 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -290,787 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 71,886 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -364,712 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | -33,275 | USD | 273 |
| 2013-01-01 to 2013-09-30 | -3,492 | USD | 273 |
Inspect the source
- Entity
- Revolutions Medical CORP / CIK 0001041009
- Captured
- SEC response SHA-256
147399b6fb66b811b6d2c30d5167ca16121e9239b95a8a07106a6bdf6bbf37d5
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001041009.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))